Highest-materiality recent filing
Revium Rx COO, President and Director Inna Martin resigns due to differences in expectations
Inna Martin resigned as Director, COO, and President effective June 16, 2026, due to differences in expectations with the company.
Revium Rx CFO Arie Gordashnikov resigns; Igor Bluvstein appointed effective May 27, 2026
Arie Gordashnikov resigned as CFO effective May 27, 2026, with no disagreement with the company.
On May 27, 2026, our Board of Directors appointed Mr. Igor Bluvstein to serve as the Chief Financial Officer of the Company and of its subsidiaries, effective immediately.
On May 27, 2026, Mr. Arie Gordashnikov resigned from his position as Chief Financial Officer of Revium Rx.
Max materiality 0.65 · Median 0.60 · Most common event leadership